The therapeutic potential of interleukin-6 hyperagonists and antagonists

Expert Opinion on Investigational Drugs

Volumn 6, Issue 3, 1997, Pages 237-266

  Kallen, K J ^a   Meyer Zum Buschenfelde, K H ^a   Rose John, S ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

antagonist; Castleman's disease; cytokine; interleukin 6; multiple myeloma; Paget's disease; POEMS syndrome; receptor

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR AGONIST; INTERLEUKIN 6 RECEPTOR ANTAGONIST; MONOCLONAL ANTIBODY; RECEPTOR SUBUNIT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANIMAL MODEL; AUTOIMMUNITY; BONE DISEASE; CLINICAL TRIAL; CROW FUKASE SYNDROME; DRUG THERAPY; ETIOLOGY; HEART INFARCTION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; MULTIPLE MYELOMA; NONHUMAN; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; RHEUMATIC DISEASE; STRUCTURE ACTIVITY RELATION; UNSTABLE ANGINA PECTORIS;

EID: 0030941553     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.3.237     Document Type: Review

References (284)